MOH — authorised 18 June 1959
- Marketing authorisation holder: PHARMACIA AND UPJOHN
- Status: likely_approved
🇮🇱 Depo-Provera in Israel
MOH authorised Depo-Provera on 18 June 1959
Marketing authorisation
Depo-Provera in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Israel
Frequently asked questions
Is Depo-Provera approved in Israel?
Yes. MOH authorised it on 18 June 1959.
Who is the marketing authorisation holder for Depo-Provera in Israel?
PHARMACIA AND UPJOHN holds the Israeli marketing authorisation.